Precigen Inc (OQ:PGEN)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 2/20 Apr 1/20 Lehr Donald P. Direct Ownership Common Stock S - Open market or private sale -5,450 $3.01
Apr 2/20 Apr 1/20 Perez Jeffrey Thomas Direct Ownership Common Stock S - Open market or private sale -4,927 $3.01
Apr 2/20 Apr 1/20 Sabzevari Helen Direct Ownership Common Stock S - Open market or private sale -5,450 $3.01
Apr 2/20 Apr 1/20 Sterling Rick L. Direct Ownership Common Stock S - Open market or private sale -4,927 $3.02
Apr 2/20 Mar 31/20 Kirk Randal J Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 76,628 $2.61
Apr 2/20 Mar 31/20 Lehr Donald P. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Apr 2/20 Mar 31/20 Lehr Donald P. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,340  
Apr 2/20 Mar 31/20 Perez Jeffrey Thomas Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Apr 2/20 Mar 31/20 Perez Jeffrey Thomas Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,340  
Apr 2/20 Mar 31/20 Sabzevari Helen Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 2/20 Mar 31/20 Kirk Randal J Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 76,628 $2.61
Apr 2/20 Mar 31/20 Lehr Donald P. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Apr 2/20 Apr 1/20 Lehr Donald P. Direct Ownership Common Stock S - Open market or private sale -5,450 $3.01
Apr 2/20 Mar 31/20 Lehr Donald P. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,340  
Apr 2/20 Mar 31/20 Perez Jeffrey Thomas Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Apr 2/20 Apr 1/20 Perez Jeffrey Thomas Direct Ownership Common Stock S - Open market or private sale -4,927 $3.01
Apr 2/20 Mar 31/20 Perez Jeffrey Thomas Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,340  
Apr 2/20 Mar 31/20 Sabzevari Helen Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -14,340  
Apr 2/20 Apr 1/20 Sabzevari Helen Direct Ownership Common Stock S - Open market or private sale -5,450 $3.01
Apr 2/20 Mar 31/20 Sabzevari Helen Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,340  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PGEN

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)